26.03 - Ndays 2025 _ Brochure_Clinical_Cases - Flipbook - Page 53
CLINICAL CASE
Secondary correction
of the nose by PEG-HA
Dr. Francesca De Angelis
Plastic surgeon,
Italy
REPORT SUMMARY
PATIENT
A 40-year-old woman sought correction
after failed rhinoplasty with inverted
V deformity, dorsal hump, and valve
collapse.
TREATMENTS
Surgical revision was excluded due
to lack of cartilage support and prior
trauma. Neauvia Intense (PEG-HA 28
mg/ml) was used as a structural rhinofiller.
In 2018, 1 ml was injected with a 22G
BEFORE
cannula under SMAS, mimicking grafts
(extension, spreader, strut), followed by a
1 ml touch-up in 2022.
RESULTS
Results remained natural and stable over
7+ years, demonstrating durability and
graft-like integration.
AFTER
FILLERS
INTENSE
Neauvia products are for trained experts only. Use must follow approved indications and the Instructions for Use (IFU) in accordance to
applicable laws and regulations in each country. Physicians are solely responsible for any treatments outside these conditions. The results
shown are specific to an individual treatment plan. Treatment decisions must be adapted to each patient, who may respond differently
based on numerous factors. Outcomes are variable and not guaranteed.
51
